{"gene":"TBX20","run_date":"2026-06-10T10:51:54","timeline":{"discoveries":[{"year":2005,"finding":"TBX5 and TBX20 physically interact; interaction domains were mapped by pulldown assays in Xenopus, and the two proteins act synergistically during early heart development. Blocking either gene alone produces similar cardiac phenotypes, demonstrating non-redundant but cooperative roles.","method":"Co-immunoprecipitation / pulldown, morpholino knockdown, cardiac physiology analysis in Xenopus","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal physical interaction mapped with domain analysis, supported by in vivo genetic synergy in Xenopus and replicated context in multiple papers","pmids":["15634698"],"is_preprint":false},{"year":2004,"finding":"The C-terminal region of TBX20 functions as a transcriptional repressor, while the C-terminus of TBX5 is an activator. TBX20 represses the ANF promoter activity via TBE2, and also inhibits TBX5-mediated activation. BMP2, but not BMP2 for TBX5, induces TBX20 expression in cardiogenic explants.","method":"Luciferase reporter assays in cultured cells, promoter deletion analysis, recombinant BMP2 treatment of chick cardiogenic explants, real-time RT-PCR","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro transcriptional assays with deletion mutants identifying functional domains, combined with explant BMP2 induction experiment","pmids":["14978031"],"is_preprint":false},{"year":2005,"finding":"Tbx20 loss-of-function in mice causes ectopic activation of Tbx2 across the entire heart myogenic field; Tbx20 is a transcriptional repressor that acts upstream of Tbx2 in the cardiac genetic hierarchy, placing Tbx20 upstream of Tbx2 in chamber vs. non-chamber myocardium lineage decisions.","method":"Gene targeting (knockout mouse), in situ hybridization, molecular marker analysis","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout with defined molecular phenotype, replicated in multiple independent mouse knockout papers","pmids":["15843414","15901664"],"is_preprint":false},{"year":2005,"finding":"Complete Tbx20 knockdown in mouse embryos causes hypoplasia of the outflow tract and right ventricle with decreased expression of Nkx2-5 and Mef2c. Tbx20 synergizes with Isl1 and Gata4 to activate both the Mef2c AHF enhancer and the Nkx2-5 cardiac enhancer in cultured cells, providing a mechanism for gene activation in the anterior heart field.","method":"Transgenic RNA interference in ES cell-derived mouse embryos, luciferase reporter/enhancer assays, transgenic mouse enhancer analysis","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — graded loss-of-function series combined with enhancer assays and in vivo transgenic validation; two independent papers confirm Tbx20 upstream of Nkx2-5/Mef2c","pmids":["15843409"],"is_preprint":false},{"year":2007,"finding":"Missense mutation I152M within the TBX20 T-box DNA-binding domain disrupts the structure and function of the TBX20 T-box as shown by biophysical characterization of purified recombinant wild-type and mutant proteins. TBX20 physically interacts with NKX2-5, GATA4, and TBX5.","method":"Biophysical characterization of recombinant proteins (circular dichroism, fluorescence), functional assays of mutant proteins","journal":"American Journal of Human Genetics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro biophysical characterization with wild-type vs. mutant protein comparison; previously known interaction partners confirmed","pmids":["17668378"],"is_preprint":false},{"year":2009,"finding":"Tbx20 suppresses Tbx2 expression in developing cardiac chambers not by direct transcriptional repression of the Tbx2 gene, but by binding Smad1 and Smad5 and sequestering them from Smad4, thereby attenuating BMP/Smad-dependent activation of Tbx2. This was demonstrated using transfection and co-localization studies with DNA-binding-deficient Tbx20 mutants.","method":"Tbx20/Tbx2 single and double knockout mouse embryos, transfection assays, co-immunoprecipitation of Tbx20 with Smad1/Smad5, localization studies, BMP/Smad enhancer analysis","journal":"Circulation Research","confidence":"High","confidence_rationale":"Tier 2 / Strong — physical interaction (Tbx20-Smad1/5) confirmed by Co-IP, mechanism validated with DNA-binding mutant Tbx20, supported by double-KO genetic epistasis","pmids":["19661464"],"is_preprint":false},{"year":2009,"finding":"The TBX20 T-box preferentially binds a T-half-site as optimal DNA recognition sequence, and distinct T-boxes show significant differences in binding affinity, kinetics, and conformational stability; the Tbx20 T-box exhibits molten globule character as shown using purified recombinant domains.","method":"In vitro DNA-binding assays with purified recombinant T-box domains, SELEX-type binding site determination, biophysical characterization (circular dichroism)","journal":"Journal of Molecular Biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted in vitro binding with purified domains, biophysical characterization, single study with multiple orthogonal methods","pmids":["19414016"],"is_preprint":false},{"year":2009,"finding":"A gain-of-function mutation I121M in the TBX20 T-box domain alters tertiary hydrophobic interactions producing a more dynamic protein structure, leading to enhanced transcriptional activity and increased co-factor interactions with GATA4/5 and NKX2-5, as well as increased occupancy on target gene DNA.","method":"Surface plasmon resonance, CD spectropolarimetry, fluorescence spectrophotometry, luciferase assay, chromatin immunoprecipitation","journal":"Journal of Medical Genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal biophysical and functional methods in single study characterizing gain-of-function mechanism","pmids":["19762328"],"is_preprint":false},{"year":2010,"finding":"BMP/SMAD1 signaling directly activates Tbx20 transcription through a conserved 334 bp cardiac regulatory element containing novel non-canonical SMAD-binding sites; phospho-SMAD1 directly binds this element in vivo. Blocking SMAD1 signaling specifically abolishes Tbx20 transcription in the developing heart.","method":"Transgenic reporter analysis in Xenopus and zebrafish and mouse; SMAD1 ChIP in vivo; SMAD1-binding site mutagenesis; morpholino knockdown of SMAD1 signaling","journal":"Development","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct ChIP of phospho-SMAD1 on Tbx20 enhancer, mutagenesis of binding sites, and transgenic validation in three species","pmids":["20460370"],"is_preprint":false},{"year":2011,"finding":"Tbx20 is a downstream transcriptional mediator of BMP10; BMP10 induces Tbx20 promoter activity through a conserved Smad binding site in the Tbx20 promoter proximal region. Tbx20 overexpression in myocardium phenocopies elevated BMP10 effects on ventricular wall development.","method":"Affymetrix exon arrays, quantitative RT-PCR, in situ hybridization, promoter luciferase assay with Smad binding site analysis, transgenic mouse overexpression","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — promoter Smad binding site identified and functionally validated, phenocopy in transgenic mice, multiple orthogonal methods","pmids":["21890625"],"is_preprint":false},{"year":2011,"finding":"Myocardial Tbx20 is required for AVC constriction and endocardial EMT; Tbx20 maintains Bmp2 expression in AVC myocardium, and re-expression of Bmp2 substantially rescues the EMT defects caused by Tbx20 loss, establishing a Tbx20→Bmp2 pathway in AVC development.","method":"Conditional knockout mouse (AVC myocardium), in situ hybridization, rescue experiment with Bmp2 re-expression","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with specific cellular phenotype, genetic rescue with Bmp2 confirms epistatic relationship","pmids":["21983003"],"is_preprint":false},{"year":2011,"finding":"Adult cardiomyocyte-specific ablation of Tbx20 results in rapid onset of severe cardiomyopathy with arrhythmias and death within 1–2 weeks. Genome-wide ChIP analysis identified direct Tbx20 binding targets in adult heart including ion channel, cytoskeletal, and transcription factor genes; a novel DNA-binding site for Tbx20 was also identified.","method":"Conditional adult cardiomyocyte-specific Tbx20 knockout, genome-wide ChIP-seq, transcriptome analysis","journal":"Journal of Clinical Investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-seq combined with conditional KO and transcriptome analysis; replicated in subsequent paper (PMID 22328084)","pmids":["22080862"],"is_preprint":false},{"year":2012,"finding":"Genome-wide ChIP coupled with RNA-seq in adult Tbx20 conditional KO hearts revealed TBX20 functions as both a transcriptional activator and repressor, each function regulating distinct gene programs. TBX20 binds targets in a context-dependent manner, using different cohorts of co-factors.","method":"Genome-wide ChIP-seq, RNA-seq, conditional adult cardiomyocyte KO","journal":"Human Molecular Genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP + transcriptome in same KO model, two orthogonal methods in single lab building on PMID 22080862","pmids":["22328084"],"is_preprint":false},{"year":2013,"finding":"Tbx20 associates with a chromatin remodeling complex composed of TLE/Groucho corepressors, NuRD complex members, RUVBL1/RUVBL2, and T-box repressor Tbx18. The interaction with TLE corepressors is mediated via an EH1 (engrailed homology 1) motif in Tbx20; ablation of this motif disrupts the repression network and Tbx20 function in vivo.","method":"Immunoaffinity purification of tagged Tbx20 + GeLC-MS/MS proteomics, Co-IP validation in embryonic mouse heart, EH1 motif mutagenesis in vivo","journal":"Journal of Proteome Research","confidence":"High","confidence_rationale":"Tier 2 / Strong — unbiased proteomics + reciprocal Co-IP in embryonic heart + in vivo mutagenesis of interaction motif; multiple orthogonal methods","pmids":["24024827"],"is_preprint":false},{"year":2013,"finding":"Tbx20 overexpression in postnatal and adult cardiomyocytes activates BMP2/pSmad1/5/8 and PI3K/AKT/GSK3β/β-catenin signaling pathways, promoting cardiomyocyte proliferation; inhibition of PI3K/AKT/GSK3β/β-catenin reduces but does not eliminate Tbx20-mediated proliferation, indicating parallel regulatory pathways downstream of BMP/Smad1/5/8.","method":"Cardiomyocyte-specific Tbx20 gain-of-function mouse, neonatal rat cardiomyocyte culture, PI3K inhibition, Western blot for pathway intermediates","journal":"Journal of Molecular and Cellular Cardiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo gain-of-function plus in vitro pathway inhibition, single lab, two orthogonal methods","pmids":["23751911"],"is_preprint":false},{"year":2013,"finding":"Endocardial Tbx20 is required for valve endocardial cell proliferation and extracellular matrix development but not for initiation of EMT. Tbx20 ablation in endocardial cells causes aberrant Wnt/β-catenin signaling, and Tbx20 regulates Lef1, a key transcriptional mediator of Wnt/β-catenin signaling.","method":"Endocardial-specific conditional Tbx20 knockout, β-catenin immunostaining, qRT-PCR for Wnt target genes","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with defined molecular pathway, single lab","pmids":["23824573"],"is_preprint":false},{"year":2016,"finding":"Tbx20 overexpression in adult cardiomyocytes directly represses cell-cycle inhibitory genes p21, Meis1, and Btg2 as demonstrated by ChIP in neonatal cardiomyocytes. Tbx20 overexpression activates multiple pro-proliferation pathways including Akt, YAP, and BMP.","method":"Adult cardiomyocyte-specific Tbx20 overexpression in mice, ChIP assay for direct binding to p21/Meis1/Btg2 promoters, cardiac functional assessment after MI","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrates direct Tbx20 binding to target cell-cycle inhibitory genes, supported by in vivo gain-of-function with multiple functional readouts","pmids":["26841808"],"is_preprint":false},{"year":2017,"finding":"TBX20 controls expression of the KCNH2 gene (encoding hERG channels) in human iPSC-derived cardiomyocytes; Tbx20 enhances KCNH2 gene expression and hERG currents, shortening action potential duration. A TBX20 p.R311C mutation specifically disables TBX20's pro-transcriptional activity over KCNH2 without affecting nuclear distribution.","method":"hiPSC-derived cardiomyocytes, electrophysiology (patch clamp), RT-qPCR, gene expression analysis of other channels","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Moderate — functional electrophysiology in human iPSC-CMs combined with mutant analysis, direct measurement of KCNH2/hERG current","pmids":["28049825"],"is_preprint":false},{"year":2017,"finding":"TBX20 physically and genetically interacts with transcription factor CASZ1; this interaction is required for survival since double heterozygous Tbx20/Casz1 mice die postnatally of dilated cardiomyopathy. A DCM-associated TBX20 mutation sterically disrupts the TBX20-CASZ1 interaction. Quantitative proteomics defined molecular pathways mis-regulated upon disruption of this complex.","method":"Unbiased proteomic screen (immunoaffinity purification + MS), Co-IP, structural studies, Tbx20+Casz1 double heterozygous mouse genetic model, quantitative proteomics","journal":"PLoS Genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, structural basis of interaction, genetic epistasis in double-het mice, quantitative proteomics; multiple orthogonal methods","pmids":["28945738"],"is_preprint":false},{"year":2018,"finding":"TBX20 regulates angiogenesis through transcriptional activation of PROK2 (prokineticin 2); TBX20 knockdown reduces PROK2 expression and impairs endothelial cell migration and angiogenesis. Overexpression of prok2 or prokr1a rescues impaired angiogenesis in tbx20-deficient zebrafish, placing TBX20 upstream of the PROK2-PROKR1 pathway.","method":"TBX20 siRNA knockdown, Matrigel plug angiogenesis assay, zebrafish tbx20 morpholino and CRISPR/Cas9 knockout, prok2/prokr1a overexpression rescue, angiogenesis gene array","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function in multiple systems (cell culture, mouse, zebrafish), genetic rescue experiments establishing epistasis, gene array identification of downstream target","pmids":["29545372"],"is_preprint":false},{"year":2018,"finding":"Mid-gestation cardiomyocyte-specific Tbx20 ablation reduces cardiomyocyte proliferation and arrests cells at G1-S phase transition. TBX20 ChIP-seq from embryonic heart identified direct targets including key cell cycle genes and atrial/ventricular specific genes. TBX20 binds a conserved enhancer for COUP-TFII/Nr2f2 and directly activates genes required for atrial identity.","method":"Inducible cardiomyocyte-specific Tbx20 KO, cell cycle analysis, genome-wide transcriptome, TBX20 ChIP-seq from embryonic heart, transgenic enhancer assay","journal":"Circulation Research","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq plus conditional KO plus transgenic enhancer validation; multiple orthogonal methods in one study","pmids":["29903739"],"is_preprint":false},{"year":2016,"finding":"Endocardial TBX20 directly regulates versican (Vcan) expression through binding to a conserved long-range enhancer identified by ATAC-seq and ChIP-seq intersection with chromatin loop maps. The Vcan enhancer drives reporter expression in endocardial lineages in a TBX20-binding site-dependent manner.","method":"Endocardial Tbx20 conditional KO, ATAC-seq, TBX20 ChIP-seq, Hi-C chromatin loop maps, transgenic reporter assay with TBX20 binding site mutation","journal":"Journal of Clinical Investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — ATAC-seq + ChIP-seq + Hi-C + transgenic reporter with binding site mutagenesis; multiple orthogonal methods identifying direct regulatory mechanism","pmids":["27348591"],"is_preprint":false},{"year":2006,"finding":"Tbx20 is required for tangential migration of facial motor neurons, lateral migration of trigeminal cells, and trans-median movement of vestibuloacoustic neurons. Facial cell migration defects were associated with coordinate downregulation of multiple planar cell polarity pathway components (Fzd7, Wnt11, Prickle1, Vang1, Vang2), identifying Tbx20 as a positive regulator of non-canonical Wnt signaling in these neurons.","method":"Conditional Tbx20-null mice (neuron-specific deletion), in situ hybridization, immunohistochemistry for PCP pathway components","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with specific migration phenotype and molecular pathway correlation; single lab","pmids":["17119020"],"is_preprint":false},{"year":2013,"finding":"Tbx20 directly regulates Esrra (estrogen-related receptor alpha) expression as determined by ChIP analysis; Tbx20 overexpression reduces H2O2-induced cardiomyocyte apoptosis via inhibition of p38MAPK, Bax, and caspase3 and activation of Bcl-2. Estrogen upregulates Tbx20 expression to mediate cardioprotection.","method":"ChIP assay for Tbx20 binding to Esrra locus, Tbx20 overexpression/knockdown in neonatal rat cardiomyocytes and H9c2 cells, Western blot for apoptotic markers","journal":"International Journal of Cardiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP shows direct Tbx20-Esrra interaction, combined with functional apoptosis assays; single lab","pmids":["23871353"],"is_preprint":false},{"year":2011,"finding":"MKLN1 (muskelin) directly binds the T-box DNA-binding domain of TBX20b isoform (but not other TBX20 isoforms) via its kelch repeats domain; the two proteins co-localize primarily in the cytoplasm when co-transfected. The interaction was identified by yeast two-hybrid screening of embryonic mouse heart cDNA library.","method":"Yeast two-hybrid screen, domain-mapping in mammalian cells, immunofluorescence colocalization, immunohistochemistry in embryonic mouse hearts","journal":"Biochemical and Biophysical Research Communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — yeast two-hybrid plus cellular colocalization; isoform specificity characterized but functional consequence not fully established","pmids":["21586270"],"is_preprint":false},{"year":2020,"finding":"TBX20 colocalizes with MEF2C, GATA4, and TBX5 (MGT) at cardiac gene enhancers associated with heart contraction in human iPSC-derived cardiomyocytes, promotes chromatin binding and co-occupancy of MGT factors at these loci, and synergizes for more robust activation of target gene transcription. Mechanistically shown by ChIP-seq and ATAC-seq.","method":"Transcriptomic comparison, ChIP-seq, ATAC-seq, human direct cardiac reprogramming, functional assays (contractility, calcium oscillation, mitochondrial respiration)","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP-seq + ATAC-seq + epigenomic approaches in human reprogramming system with functional validation; multiple orthogonal methods","pmids":["36102189"],"is_preprint":false},{"year":2020,"finding":"Tbx20 induction in adult zebrafish myocardium promotes cardiomyocyte dedifferentiation (loss of cellular contacts, re-expression of fetal gene programs) and non-cell-autonomously induces endocardial Bmp6 signaling. Pharmacological inhibition of endocardial Bmp6 attenuates endocardial regeneration in tbx20-overexpressing hearts.","method":"Adult zebrafish cardiac injury models, cardiomyocyte-specific Tbx20 overexpression, pharmacological Bmp6 inhibition, Id1/Id2b expression analysis","journal":"Frontiers in Cell and Developmental Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo gain-of-function with pharmacological pathway inhibition; single lab in zebrafish","pmids":["32850848"],"is_preprint":false},{"year":2008,"finding":"TFAP2 transcription factors function as repressors of the TBX20 gene in vitro and in vivo through functional binding sites within a 100 bp core promoter region of human TBX20; decreased TFAP2C levels were found in cardiac biopsies of TOF patients.","method":"TBX20 promoter luciferase reporter assay, identification of TFAP2 binding sites, in vivo validation in cardiac biopsies","journal":"Journal of Cellular Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional promoter analysis with binding site identification plus in vivo biological context; single lab","pmids":["18275040"],"is_preprint":false},{"year":2022,"finding":"TBX20 suppresses colorectal cancer cell proliferation by impairing non-homologous end joining (NHEJ)-mediated DNA double-strand break repair via direct binding to the middle domains of both Ku70 and Ku80, inhibiting their recruitment to chromatin. PDZRN3 was identified as the E3 ubiquitin ligase mediating TBX20 ubiquitination and degradation.","method":"Co-immunoprecipitation with Ku70/Ku80 domain mapping, chromatin fractionation, NHEJ repair assay, ubiquitination assay identifying PDZRN3 as E3 ligase","journal":"Cancer Science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with domain mapping, chromatin recruitment assay, and ubiquitination assay; single lab but multiple orthogonal methods","pmids":["35348274"],"is_preprint":false},{"year":2023,"finding":"ER stress upregulates Tbx20 via the ATF6 arm of the unfolded protein response; Tbx20 in turn activates downstream BMP2-pSmad1/5/8 signaling to induce cardiomyocyte proliferation and limit apoptosis. Administration of recombinant Bmp2 further upregulates Tbx20, establishing a feed-forward loop.","method":"ER stress induction in neonatal rat cardiomyocytes and in vivo, ATF6 pathway inhibition, Tbx20 cardiomyocyte-specific conditional KO, recombinant Bmp2 rescue experiment, Western blot for pSmad1/5/8","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO + pharmacological pathway dissection + genetic rescue; single lab","pmids":["36805334"],"is_preprint":false},{"year":2023,"finding":"TBX20 mutations p.His232Arg and p.Asp288His reduce transactivation of the KCNH2 target gene and impair binding to the KCNH2 promoter without affecting nuclear distribution of TBX20; these mutations co-segregate with atrial fibrillation and map to a new AF locus at chromosome 7p14.2-p14.3.","method":"Linkage analysis, exome sequencing, Sanger sequencing, dual-luciferase reporter assay, promoter-binding assay","journal":"Biology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — reporter assay and DNA binding assay with mutant proteins; functional demonstration of mechanism but no ChIP or in vivo validation","pmids":["37759586"],"is_preprint":false},{"year":2023,"finding":"Disruption of the Tbx20-TLE interaction (via EH1 domain two-amino-acid substitution knock-in mouse) impairs cardiac looping and chamber formation, with transcriptional profiling revealing misexpression of the retinoic acid pathway and cardiac progenitor genes in the second heart field.","method":"EH1 domain knock-in mouse model (two amino acid substitution disrupting TLE interaction), RNA-seq transcriptional profiling, cardiac morphology analysis","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — targeted in vivo mutagenesis of specific interaction domain with defined morphogenetic and transcriptional phenotype; validates earlier proteomic discovery (PMID 24024827)","pmids":["37756602"],"is_preprint":false},{"year":2020,"finding":"Tbx20 directly activates Hey2 expression in embryonic mouse ventricles through a distal enhancer; mutation/deletion of conserved T-box binding sites in the enhancer abolishes activity, and Tbx20 null mice completely lose the enhancer activity. Luciferase assays show Tbx20 controls enhancer activity through DNA binding and cooperative function with cardiac Gata proteins.","method":"Enhancer deletion mouse model, Tbx20 null mouse enhancer analysis, luciferase reporter assays with T-box and Gata binding site mutations","journal":"Developmental Biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo enhancer deletion + Tbx20 null validation + luciferase with site mutagenesis; multiple orthogonal methods","pmids":["32035085"],"is_preprint":false},{"year":2025,"finding":"In retinal ganglion cells, Tbx20 is expressed predominantly in M1, M2, M6 ipRGC subtypes and is required for their development; conditional deletion of Tbx20 causes failure of Tbx20-expressing cells to develop and downregulates Opn4 expression, establishing Tbx20 as a key downstream factor of Tbr2 in ipRGC subtype specification.","method":"Conditional Tbx20 deletion in retinal neurons (Tbr2-Cre), single-cell RNA-seq subtype profiling, Opn4 expression analysis","journal":"bioRxiv (preprint)","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — conditional KO with defined cellular phenotype in retina; preprint, not yet peer-reviewed","pmids":["bio_10.1101_2025.04.29.651262"],"is_preprint":true}],"current_model":"TBX20 is a T-box transcription factor that functions as both a transcriptional activator and repressor in the heart by binding T-half-site DNA sequences and assembling context-dependent complexes: it interacts with cardiac co-factors NKX2-5, GATA4, TBX5, ISL1, and CASZ1 to activate chamber-specific gene programs (including KCNH2/hERG, Hey2, COUP-TFII enhancers, and cell-cycle genes), while recruiting a TLE/Groucho-NuRD corepressor complex via its EH1 motif to repress Tbx2 and other non-chamber genes, with BMP/SMAD1 signaling acting directly upstream to drive Tbx20 transcription, and Tbx20 itself attenuating BMP/Smad signaling by sequestering Smad1/5 from Smad4 to restrict Tbx2 to the AVC; in adult cardiomyocytes, Tbx20 maintains ion channel and cytoskeletal gene expression, directly represses cell-cycle inhibitors p21/Meis1/Btg2 to promote proliferation, and regulates angiogenesis via the PROK2-PROKR1 pathway."},"narrative":{"mechanistic_narrative":"TBX20 is a cardiac T-box transcription factor that binds T-half-site DNA and acts as both an activator and a repressor to assemble context-dependent regulatory complexes governing chamber specification, cardiomyocyte proliferation, and adult heart homeostasis [PMID:19414016, PMID:22328084]. As an activator, TBX20 synergizes with the core cardiac cofactors NKX2-5, GATA4, TBX5, ISL1, MEF2C and CASZ1 to drive enhancers for anterior-heart-field genes (Mef2c, Nkx2-5), chamber-identity genes (Hey2, COUP-TFII/Nr2f2), and the hERG channel gene KCNH2, and to direct atrial/ventricular gene programs [PMID:15843409, PMID:17668378, PMID:28945738, PMID:29903739, PMID:36102189, PMID:32035085, PMID:28049825]. As a repressor, TBX20 recruits a TLE/Groucho-NuRD corepressor complex (with RUVBL1/2 and TBX18) through an EH1 motif, an interaction required for cardiac looping and chamber formation [PMID:24024827, PMID:37756602]. TBX20 restricts the non-chamber gene Tbx2 to the AVC not by direct repression but by binding SMAD1/SMAD5 and sequestering them from SMAD4, thereby attenuating BMP/Smad signaling [PMID:19661464, PMID:15843414, PMID:15901664]. BMP/SMAD1 signaling, in turn, acts directly upstream to activate Tbx20 transcription, creating a regulatory circuit [PMID:20460370, PMID:21890625]. In adult and postnatal cardiomyocytes TBX20 maintains ion-channel and cytoskeletal gene expression, and promotes proliferation by directly repressing the cell-cycle inhibitors p21, Meis1 and Btg2 and by engaging BMP/Smad and PI3K/AKT pathways [PMID:22080862, PMID:26841808, PMID:23751911, PMID:29903739]. TBX20 also regulates endocardial valve development through versican and Wnt/Lef1 [PMID:27348591, PMID:23824573] and controls angiogenesis via the PROK2-PROKR1 pathway [PMID:29545372]. Disease-associated T-box mutations alter protein structure, cofactor binding, and target activation: structural T-box mutations cause congenital heart defects [PMID:17668378, PMID:19762328], a CASZ1-disrupting mutation underlies dilated cardiomyopathy [PMID:28945738], and KCNH2-promoter-binding mutations co-segregate with atrial fibrillation [PMID:37759586, PMID:28049825]. Beyond the heart, TBX20 functions in facial/vestibuloacoustic neuron migration via planar cell polarity components [PMID:17119020] and in retinal ganglion cell subtype specification [PMID:bio_10.1101_2025.04.29.651262].","teleology":[{"year":2004,"claim":"Established that TBX20 carries an intrinsic transcriptional repressor function distinct from the activator TBX5 and that BMP2 induces its expression, framing TBX20 as a BMP-responsive repressive arm of cardiac gene control.","evidence":"Luciferase reporter/promoter deletion assays and BMP2 treatment of chick cardiogenic explants","pmids":["14978031"],"confidence":"High","gaps":["In vitro reporter context only","Endogenous repression targets not yet defined","BMP-to-Tbx20 enhancer not yet mapped"]},{"year":2005,"claim":"Defined TBX20's place in the cardiac genetic hierarchy: it physically partners with TBX5 and acts upstream of Tbx2 to enforce chamber versus non-chamber myocardium identity, and synergizes with Isl1/Gata4 to activate Nkx2-5 and Mef2c in the anterior heart field.","evidence":"Co-IP and morpholino knockdown in Xenopus, knockout mice with marker analysis, enhancer/luciferase and transgenic assays","pmids":["15634698","15843414","15901664","15843409"],"confidence":"High","gaps":["Mechanism of Tbx2 repression unresolved at this stage","Direct vs indirect activation of Nkx2-5/Mef2c not separated"]},{"year":2009,"claim":"Resolved how TBX20 represses Tbx2 — not by direct DNA binding but by sequestering SMAD1/5 from SMAD4 — and defined its preferred T-half-site recognition sequence with molten-globule biophysics of the T-box.","evidence":"Single/double knockout mice, Co-IP of Tbx20 with Smad1/5, DNA-binding-deficient mutants, SELEX-type binding and CD on purified domains","pmids":["19661464","19414016"],"confidence":"High","gaps":["Stoichiometry of Smad sequestration not quantified","Genome-wide direct binding map still absent"]},{"year":2010,"claim":"Closed the regulatory loop upstream of TBX20 by showing phospho-SMAD1 directly binds a conserved cardiac enhancer to activate Tbx20 transcription, and that BMP10 feeds the same Smad-dependent promoter element.","evidence":"In vivo SMAD1 ChIP, binding-site mutagenesis, transgenic reporters across three species, BMP10 promoter assays and overexpression mice","pmids":["20460370","21890625"],"confidence":"High","gaps":["Tissue-specific cofactors at the SMAD enhancer not defined","Feedback timing relative to Tbx20-Smad sequestration not modeled"]},{"year":2011,"claim":"Demonstrated TBX20 is continuously required in the adult heart for survival and identified its genome-wide direct targets, establishing a maintenance role over ion-channel, cytoskeletal, and transcription-factor genes; also placed Tbx20 upstream of Bmp2 in AVC EMT.","evidence":"Conditional adult cardiomyocyte KO with genome-wide ChIP-seq and transcriptomics; conditional AVC KO with Bmp2 rescue","pmids":["22080862","21983003"],"confidence":"High","gaps":["Activator vs repressor target partition not yet separated","Cofactor identity at adult binding sites unknown"]},{"year":2012,"claim":"Resolved that TBX20 operates as both activator and repressor over distinct gene cohorts in a context-dependent, cofactor-dependent manner.","evidence":"Genome-wide ChIP-seq plus RNA-seq in adult conditional KO hearts","pmids":["22328084"],"confidence":"High","gaps":["Specific cofactors that switch activator/repressor mode not all identified"]},{"year":2013,"claim":"Defined the molecular machinery of TBX20-mediated repression — an EH1-tethered TLE/Groucho-NuRD-RUVBL1/2-TBX18 complex — and linked TBX20 gain-of-function to proliferative BMP/Smad and PI3K/AKT signaling and to endocardial Wnt/Lef1 control.","evidence":"Tagged-Tbx20 immunoaffinity proteomics with Co-IP and EH1 mutagenesis; gain-of-function mice with pathway inhibition; endocardial conditional KO with Wnt target analysis","pmids":["24024827","23751911","23824573"],"confidence":"High","gaps":["Direct vs indirect contribution of each corepressor subunit unresolved","Proliferation pathway findings from a single lab"]},{"year":2016,"claim":"Established the direct mechanism by which TBX20 drives cardiomyocyte proliferation — repression of the cell-cycle inhibitors p21, Meis1, and Btg2 — and mapped a direct endocardial enhancer for versican.","evidence":"ChIP for direct promoter binding plus in vivo gain-of-function after MI; ATAC-seq/ChIP-seq/Hi-C with binding-site-mutant reporter for Vcan","pmids":["26841808","27348591"],"confidence":"High","gaps":["Durability of induced proliferation not established","Endocardial vs myocardial target overlap not compared"]},{"year":2017,"claim":"Connected TBX20 to specific channelopathy and cardiomyopathy mechanisms: it activates KCNH2/hERG to shape action potential duration, and a CASZ1-binding interaction is required to prevent dilated cardiomyopathy.","evidence":"hiPSC-CM electrophysiology with mutant analysis; proteomics, Co-IP, structural studies and Tbx20/Casz1 double-het mice","pmids":["28049825","28945738"],"confidence":"High","gaps":["Full set of TBX20-CASZ1 co-regulated targets not enumerated","hERG regulation mechanism (direct vs cofactor-dependent) at promoter level partly open"]},{"year":2018,"claim":"Extended TBX20 function beyond the cardiomyocyte: it activates PROK2 to drive angiogenesis, and embryonic ChIP-seq defined its direct atrial-identity targets (COUP-TFII/Nr2f2) and cell-cycle program controlling G1-S progression.","evidence":"siRNA/zebrafish loss-of-function with prok2/prokr1a rescue and gene arrays; inducible cardiomyocyte KO with ChIP-seq and transgenic enhancer assay","pmids":["29545372","29903739"],"confidence":"High","gaps":["Endothelial vs cardiac TBX20 cofactors not compared","PROK2 regulatory element not finely mapped"]},{"year":2020,"claim":"Showed that TBX20 acts within the MEF2C/GATA4/TBX5 reprogramming cohort to promote chromatin co-occupancy and synergistic activation of contraction-gene enhancers, and that it directly activates Hey2 through a Gata-cooperative ventricular enhancer; in adult zebrafish it drives dedifferentiation and endocardial Bmp6 signaling.","evidence":"ChIP-seq/ATAC-seq in human reprogramming with functional assays; Hey2 enhancer deletion/null mouse with luciferase site mutagenesis; zebrafish overexpression with Bmp6 inhibition","pmids":["36102189","32035085","32850848"],"confidence":"High","gaps":["Order of MGT factor recruitment vs TBX20 binding not fully resolved","Zebrafish dedifferentiation findings from single lab"]},{"year":2023,"claim":"Validated the EH1-TLE repression circuit in vivo and elaborated stress-responsive and arrhythmia mechanisms: ER stress drives Tbx20 via ATF6 into a BMP2 feed-forward proliferative loop, and KCNH2-promoter-binding mutations co-segregate with atrial fibrillation.","evidence":"EH1 knock-in mouse with RNA-seq; ER-stress models with ATF6 inhibition, conditional KO and Bmp2 rescue; linkage/exome and reporter/binding assays for AF mutations","pmids":["37756602","36805334","37759586"],"confidence":"High","gaps":["Stress-loop and AF mechanisms each from single studies","AF mutations lack ChIP/in vivo validation"]},{"year":2022,"claim":"Identified a non-cardiac tumor-suppressive role: TBX20 binds Ku70/Ku80 to inhibit their chromatin recruitment and NHEJ repair, with PDZRN3 controlling TBX20 turnover.","evidence":"Co-IP with domain mapping, chromatin fractionation, NHEJ repair and ubiquitination assays in colorectal cancer cells","pmids":["35348274"],"confidence":"Medium","gaps":["Single lab","In vivo relevance to tumor suppression not established","Relationship to transcriptional function unclear"]},{"year":2025,"claim":"Extended the developmental remit of TBX20 to retinal ganglion cell subtype specification downstream of Tbr2.","evidence":"Conditional Tbx20 deletion with single-cell RNA-seq and Opn4 analysis (preprint)","pmids":["bio_10.1101_2025.04.29.651262"],"confidence":"Medium","gaps":["Preprint, not peer-reviewed","Direct vs indirect Opn4 regulation unknown","Cofactors in RGCs undefined"]},{"year":null,"claim":"How TBX20 selects between its activator and repressor cofactor cohorts at individual loci — the molecular switch governing context-dependent complex assembly — remains undefined.","evidence":"","pmids":[],"confidence":"High","gaps":["No structural model of the full TBX20 holo-complexes","Determinants of activator-vs-repressor mode selection unresolved","Post-translational regulation of TBX20 beyond PDZRN3 ubiquitination not characterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[4,12,16,20]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[6,11,32]},{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[28]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[17,30]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[11,13,21]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[4,12,20]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,3,32]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[5,8,14]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[16,20]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[28]}],"complexes":["TLE/Groucho-NuRD corepressor complex","MEF2C/GATA4/TBX5 (MGT) reprogramming complex"],"partners":["TBX5","NKX2-5","GATA4","SMAD1","CASZ1","TLE","TBX18","MKLN1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UMR3","full_name":"T-box transcription factor TBX20","aliases":[],"length_aa":447,"mass_kda":49.2,"function":"Acts as a transcriptional activator and repressor required for cardiac development and may have key roles in the maintenance of functional and structural phenotypes in adult heart","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9UMR3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TBX20","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TBX20","total_profiled":1310},"omim":[{"mim_id":"611363","title":"ATRIAL SEPTAL DEFECT 4; ASD4","url":"https://www.omim.org/entry/611363"},{"mim_id":"606061","title":"T-BOX TRANSCRIPTION FACTOR 20; TBX20","url":"https://www.omim.org/entry/606061"},{"mim_id":"600576","title":"GATA-BINDING PROTEIN 4; GATA4","url":"https://www.omim.org/entry/600576"},{"mim_id":"108800","title":"ATRIAL SEPTAL DEFECT 1; ASD1","url":"https://www.omim.org/entry/108800"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoli fibrillar center","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"heart muscle","ntpm":37.4}],"url":"https://www.proteinatlas.org/search/TBX20"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q9UMR3","domains":[{"cath_id":"2.60.40.820","chopping":"94-278","consensus_level":"high","plddt":93.5027,"start":94,"end":278}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UMR3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UMR3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UMR3-F1-predicted_aligned_error_v6.png","plddt_mean":66.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TBX20","jax_strain_url":"https://www.jax.org/strain/search?query=TBX20"},"sequence":{"accession":"Q9UMR3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UMR3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UMR3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UMR3"}},"corpus_meta":[{"pmid":"17668378","id":"PMC_17668378","title":"Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy.","date":"2007","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17668378","citation_count":281,"is_preprint":false},{"pmid":"15843409","id":"PMC_15843409","title":"Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motoneuron development.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15843409","citation_count":184,"is_preprint":false},{"pmid":"15843414","id":"PMC_15843414","title":"Murine T-box transcription factor Tbx20 acts as a repressor during heart development, and is essential for adult heart integrity, function and adaptation.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15843414","citation_count":173,"is_preprint":false},{"pmid":"15901664","id":"PMC_15901664","title":"Tbx20 is essential for cardiac chamber differentiation and repression of Tbx2.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15901664","citation_count":160,"is_preprint":false},{"pmid":"26841808","id":"PMC_26841808","title":"Overexpression of Tbx20 in Adult Cardiomyocytes Promotes Proliferation and Improves Cardiac Function After Myocardial Infarction.","date":"2016","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/26841808","citation_count":134,"is_preprint":false},{"pmid":"22080862","id":"PMC_22080862","title":"Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function.","date":"2011","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/22080862","citation_count":119,"is_preprint":false},{"pmid":"15634698","id":"PMC_15634698","title":"Tbx5 and Tbx20 act synergistically to control vertebrate heart morphogenesis.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15634698","citation_count":114,"is_preprint":false},{"pmid":"14978031","id":"PMC_14978031","title":"Differential expression and function of Tbx5 and Tbx20 in cardiac development.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14978031","citation_count":107,"is_preprint":false},{"pmid":"11118890","id":"PMC_11118890","title":"Cloning and expression analysis of the mouse T-box gene tbx20.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11118890","citation_count":107,"is_preprint":false},{"pmid":"19762328","id":"PMC_19762328","title":"A gain-of-function TBX20 mutation causes congenital atrial septal defects, patent foramen ovale and cardiac valve defects.","date":"2009","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19762328","citation_count":101,"is_preprint":false},{"pmid":"19661464","id":"PMC_19661464","title":"Tbx20 interacts with smads to confine tbx2 expression to the atrioventricular canal.","date":"2009","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/19661464","citation_count":95,"is_preprint":false},{"pmid":"19074289","id":"PMC_19074289","title":"Transcription factor neuromancer/TBX20 is required for cardiac function in Drosophila with implications for human heart disease.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19074289","citation_count":77,"is_preprint":false},{"pmid":"17119020","id":"PMC_17119020","title":"T-Box transcription factor Tbx20 regulates a genetic program for cranial motor neuron cell body migration.","date":"2006","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17119020","citation_count":73,"is_preprint":false},{"pmid":"10906473","id":"PMC_10906473","title":"tbx20, a new vertebrate T-box gene expressed in the cranial motor neurons and developing cardiovascular structures in zebrafish.","date":"2000","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/10906473","citation_count":72,"is_preprint":false},{"pmid":"23751911","id":"PMC_23751911","title":"Tbx20 promotes cardiomyocyte proliferation and persistence of fetal characteristics in adult mouse hearts.","date":"2013","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/23751911","citation_count":67,"is_preprint":false},{"pmid":"15733676","id":"PMC_15733676","title":"Neuromancer Tbx20-related genes (H15/midline) promote cell fate specification and morphogenesis of the Drosophila heart.","date":"2005","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15733676","citation_count":66,"is_preprint":false},{"pmid":"23824573","id":"PMC_23824573","title":"Tbx20 acts upstream of Wnt signaling to regulate endocardial cushion formation and valve remodeling during mouse cardiogenesis.","date":"2013","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23824573","citation_count":65,"is_preprint":false},{"pmid":"18834961","id":"PMC_18834961","title":"T-box transcription factor TBX20 mutations in Chinese patients with congenital heart disease.","date":"2008","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18834961","citation_count":64,"is_preprint":false},{"pmid":"15922573","id":"PMC_15922573","title":"Tbx20-related genes, mid and H15, are required for tinman expression, proper patterning, and normal differentiation of cardioblasts in Drosophila.","date":"2005","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/15922573","citation_count":60,"is_preprint":false},{"pmid":"36102189","id":"PMC_36102189","title":"TBX20 Improves Contractility and Mitochondrial Function During Direct Human Cardiac Reprogramming.","date":"2022","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/36102189","citation_count":59,"is_preprint":false},{"pmid":"22328084","id":"PMC_22328084","title":"Dual transcriptional activator and repressor roles of TBX20 regulate adult cardiac structure and function.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22328084","citation_count":56,"is_preprint":false},{"pmid":"29903739","id":"PMC_29903739","title":"Tbx20 Is Required in Mid-Gestation Cardiomyocytes and Plays a Central Role in Atrial Development.","date":"2018","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/29903739","citation_count":52,"is_preprint":false},{"pmid":"18275040","id":"PMC_18275040","title":"Characterization of TBX20 in human hearts and its regulation by TFAP2.","date":"2008","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18275040","citation_count":52,"is_preprint":false},{"pmid":"22226977","id":"PMC_22226977","title":"Tbx20 regulation of cardiac cell proliferation and lineage specialization during embryonic and fetal development in vivo.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22226977","citation_count":52,"is_preprint":false},{"pmid":"20460370","id":"PMC_20460370","title":"The BMP pathway acts to directly regulate Tbx20 in the developing heart.","date":"2010","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20460370","citation_count":49,"is_preprint":false},{"pmid":"21890625","id":"PMC_21890625","title":"Tbx20 transcription factor is a downstream mediator for bone morphogenetic protein-10 in regulating cardiac ventricular wall development and function.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21890625","citation_count":49,"is_preprint":false},{"pmid":"21983003","id":"PMC_21983003","title":"Myocardial Tbx20 regulates early atrioventricular canal formation and endocardial epithelial-mesenchymal transition via Bmp2.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21983003","citation_count":46,"is_preprint":false},{"pmid":"28553164","id":"PMC_28553164","title":"TBX20 loss-of-function mutation responsible for familial tetralogy of Fallot or sporadic persistent truncus arteriosus.","date":"2017","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28553164","citation_count":45,"is_preprint":false},{"pmid":"33585493","id":"PMC_33585493","title":"The Role of Tbx20 in Cardiovascular Development and Function.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33585493","citation_count":43,"is_preprint":false},{"pmid":"29545372","id":"PMC_29545372","title":"TBX20 Regulates Angiogenesis Through the Prokineticin 2-Prokineticin Receptor 1 Pathway.","date":"2018","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/29545372","citation_count":42,"is_preprint":false},{"pmid":"10936053","id":"PMC_10936053","title":"Characterization of the human TBX20 gene, a new member of the T-Box gene family closely related to the Drosophila H15 gene.","date":"2000","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/10936053","citation_count":40,"is_preprint":false},{"pmid":"11862462","id":"PMC_11862462","title":"Expression pattern of novel chick T-box gene, Tbx20.","date":"2001","source":"Development genes and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/11862462","citation_count":38,"is_preprint":false},{"pmid":"25625280","id":"PMC_25625280","title":"TBX20 loss-of-function mutation contributes to double outlet right ventricle.","date":"2015","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25625280","citation_count":37,"is_preprint":false},{"pmid":"26118961","id":"PMC_26118961","title":"TBX20 loss-of-function mutation associated with familial dilated cardiomyopathy.","date":"2016","source":"Clinical chemistry and laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26118961","citation_count":36,"is_preprint":false},{"pmid":"12536325","id":"PMC_12536325","title":"Developmental expression of the Xenopus laevis Tbx20 orthologue.","date":"2002","source":"Development genes and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/12536325","citation_count":35,"is_preprint":false},{"pmid":"24024827","id":"PMC_24024827","title":"A Gro/TLE-NuRD corepressor complex facilitates Tbx20-dependent transcriptional repression.","date":"2013","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/24024827","citation_count":34,"is_preprint":false},{"pmid":"28049825","id":"PMC_28049825","title":"Tbx20 controls the expression of the KCNH2 gene and of hERG channels.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28049825","citation_count":31,"is_preprint":false},{"pmid":"27940156","id":"PMC_27940156","title":"Tbx20 drives cardiac progenitor formation and cardiomyocyte proliferation in zebrafish.","date":"2016","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/27940156","citation_count":29,"is_preprint":false},{"pmid":"16477648","id":"PMC_16477648","title":"Developmental expression patterns of Tbx1, Tbx2, Tbx5, and Tbx20 in Xenopus tropicalis.","date":"2006","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16477648","citation_count":28,"is_preprint":false},{"pmid":"19605497","id":"PMC_19605497","title":"The Tbx20 homologs midline and H15 specify ventral fate in the Drosophila melanogaster leg.","date":"2009","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19605497","citation_count":28,"is_preprint":false},{"pmid":"20306498","id":"PMC_20306498","title":"Elevated glucose induces congenital heart defects by altering the expression of tbx5, tbx20, and has2 in developing zebrafish embryos.","date":"2010","source":"Birth defects research. Part A, Clinical and molecular teratology","url":"https://pubmed.ncbi.nlm.nih.gov/20306498","citation_count":28,"is_preprint":false},{"pmid":"30820038","id":"PMC_30820038","title":"Copy number variation analysis in bicuspid aortic valve-related aortopathy identifies TBX20 as a contributing gene.","date":"2019","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/30820038","citation_count":28,"is_preprint":false},{"pmid":"28945738","id":"PMC_28945738","title":"Formation of a TBX20-CASZ1 protein complex is protective against dilated cardiomyopathy and critical for cardiac homeostasis.","date":"2017","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28945738","citation_count":26,"is_preprint":false},{"pmid":"27510170","id":"PMC_27510170","title":"A novel TBX20 loss‑of‑function mutation contributes to adult‑onset dilated cardiomyopathy or congenital atrial septal defect.","date":"2016","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/27510170","citation_count":26,"is_preprint":false},{"pmid":"15188442","id":"PMC_15188442","title":"Expression of tbx20 RNA during chick heart development.","date":"2004","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/15188442","citation_count":25,"is_preprint":false},{"pmid":"27348591","id":"PMC_27348591","title":"Probing chromatin landscape reveals roles of endocardial TBX20 in septation.","date":"2016","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/27348591","citation_count":23,"is_preprint":false},{"pmid":"19414016","id":"PMC_19414016","title":"Conformational stability and DNA binding specificity of the cardiac T-box transcription factor Tbx20.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19414016","citation_count":23,"is_preprint":false},{"pmid":"32850848","id":"PMC_32850848","title":"Tbx20 Induction Promotes Zebrafish Heart Regeneration by Inducing Cardiomyocyte Dedifferentiation and Endocardial Expansion.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/32850848","citation_count":21,"is_preprint":false},{"pmid":"26895318","id":"PMC_26895318","title":"Role of cardiac TBX20 in dilated cardiomyopathy.","date":"2016","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26895318","citation_count":19,"is_preprint":false},{"pmid":"25183037","id":"PMC_25183037","title":"A novel variant in TBX20 (p.D176N) identified by whole-exome sequencing in combination with a congenital heart disease related gene filter is associated with familial atrial septal defect.","date":"2014","source":"Journal of Zhejiang University. Science. B","url":"https://pubmed.ncbi.nlm.nih.gov/25183037","citation_count":19,"is_preprint":false},{"pmid":"23871353","id":"PMC_23871353","title":"Tbx20 functions as an important regulator of estrogen-mediated cardiomyocyte protection during oxidative stress.","date":"2013","source":"International journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/23871353","citation_count":18,"is_preprint":false},{"pmid":"22465533","id":"PMC_22465533","title":"Genetic analysis of the TBX20 gene promoter region in patients with ventricular septal defects.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/22465533","citation_count":18,"is_preprint":false},{"pmid":"31138201","id":"PMC_31138201","title":"DNA methylation status of TBX20 in patients with tetralogy of Fallot.","date":"2019","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/31138201","citation_count":17,"is_preprint":false},{"pmid":"35348274","id":"PMC_35348274","title":"TBX20 inhibits colorectal cancer tumorigenesis by impairing NHEJ-mediated DNA repair.","date":"2022","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/35348274","citation_count":17,"is_preprint":false},{"pmid":"21185952","id":"PMC_21185952","title":"Amphioxus Tbx6/16 and Tbx20 embryonic expression patterns reveal ancestral functions in chordates.","date":"2010","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/21185952","citation_count":16,"is_preprint":false},{"pmid":"25834824","id":"PMC_25834824","title":"Novel mutations in the transcriptional activator domain of the human TBX20 in patients with atrial septal defect.","date":"2015","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/25834824","citation_count":16,"is_preprint":false},{"pmid":"27907103","id":"PMC_27907103","title":"Tbx20 Is an Essential Regulator of Embryonic Heart Growth in Zebrafish.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27907103","citation_count":15,"is_preprint":false},{"pmid":"21335279","id":"PMC_21335279","title":"Tbx20, Smads, and the atrioventricular canal.","date":"2010","source":"Trends in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21335279","citation_count":14,"is_preprint":false},{"pmid":"32035085","id":"PMC_32035085","title":"Expression of Hey2 transcription factor in the early embryonic ventricles is controlled through a distal enhancer by Tbx20 and Gata transcription factors.","date":"2020","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/32035085","citation_count":14,"is_preprint":false},{"pmid":"22814213","id":"PMC_22814213","title":"The Tbx20 homolog Midline represses wingless in conjunction with Groucho during the maintenance of segment polarity.","date":"2012","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22814213","citation_count":14,"is_preprint":false},{"pmid":"29637615","id":"PMC_29637615","title":"Cardiomyogenic differentiation of human adipose-derived mesenchymal stem cells transduced with Tbx20-encoding lentiviral vectors.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29637615","citation_count":13,"is_preprint":false},{"pmid":"36805334","id":"PMC_36805334","title":"ER stress induces upregulation of transcription factor Tbx20 and downstream Bmp2 signaling to promote cardiomyocyte survival.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36805334","citation_count":12,"is_preprint":false},{"pmid":"21586270","id":"PMC_21586270","title":"Characterization of the novel interaction between muskelin and TBX20, a critical cardiogenic transcription factor.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21586270","citation_count":12,"is_preprint":false},{"pmid":"34202524","id":"PMC_34202524","title":"The Double Mutation DSG2-p.S363X and TBX20-p.D278X Is Associated with Left Ventricular Non-Compaction Cardiomyopathy: Case Report.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34202524","citation_count":12,"is_preprint":false},{"pmid":"25487630","id":"PMC_25487630","title":"Association of TBX20 gene polymorphism with congenital heart disease in Han Chinese neonates.","date":"2014","source":"Pediatric cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/25487630","citation_count":11,"is_preprint":false},{"pmid":"30084275","id":"PMC_30084275","title":"Association between the promoter methylation of the TBX20 gene and tetralogy of fallot.","date":"2018","source":"Scandinavian cardiovascular journal : SCJ","url":"https://pubmed.ncbi.nlm.nih.gov/30084275","citation_count":10,"is_preprint":false},{"pmid":"38353104","id":"PMC_38353104","title":"Role of TBX20 Truncating Variants in Dilated Cardiomyopathy and Left Ventricular Noncompaction.","date":"2024","source":"Circulation. Genomic and precision medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38353104","citation_count":8,"is_preprint":false},{"pmid":"37759586","id":"PMC_37759586","title":"Discovery of TBX20 as a Novel Gene Underlying Atrial Fibrillation.","date":"2023","source":"Biology","url":"https://pubmed.ncbi.nlm.nih.gov/37759586","citation_count":7,"is_preprint":false},{"pmid":"27253890","id":"PMC_27253890","title":"Lack of Genetic Interaction between Tbx18 and Tbx2/Tbx20 in Mouse Epicardial Development.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27253890","citation_count":7,"is_preprint":false},{"pmid":"34150759","id":"PMC_34150759","title":"TBX20 Contributes to Balancing the Differentiation of Perivascular Adipose-Derived Stem Cells to Vascular Lineages and Neointimal Hyperplasia.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34150759","citation_count":7,"is_preprint":false},{"pmid":"37481008","id":"PMC_37481008","title":"Screening and evaluation of TBX20 and CITED2 mutations in children with congenital cardiac septal defects: Correlation with cardiac troponin T and caspase-3.","date":"2023","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/37481008","citation_count":6,"is_preprint":false},{"pmid":"23133562","id":"PMC_23133562","title":"In vitro site selection of a consensus binding site for the Drosophila melanogaster Tbx20 homolog midline.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23133562","citation_count":6,"is_preprint":false},{"pmid":"36831251","id":"PMC_36831251","title":"Epigenetic Evaluation of the TBX20 Gene and Environmental Risk Factors in Mexican Paediatric Patients with Congenital Septal Defects.","date":"2023","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36831251","citation_count":5,"is_preprint":false},{"pmid":"31524541","id":"PMC_31524541","title":"Genetic Variants at the rs4720169 Locus of TBX20 and the rs12921862 Locus of AXIN1 May Increase the Risk of Congenital Heart Defects in the Mexican Population: A Pilot Study.","date":"2019","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/31524541","citation_count":5,"is_preprint":false},{"pmid":"27034249","id":"PMC_27034249","title":"Mild decrease in TBX20 promoter activity is a potentially protective factor against congenital heart defects in the Han Chinese population.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27034249","citation_count":5,"is_preprint":false},{"pmid":"38284443","id":"PMC_38284443","title":"Genetic and functional variants of the TBX20 gene promoter in dilated cardiomyopathy.","date":"2024","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38284443","citation_count":4,"is_preprint":false},{"pmid":"27323105","id":"PMC_27323105","title":"Relationship between TBX20 gene polymorphism and congenital heart disease.","date":"2016","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/27323105","citation_count":4,"is_preprint":false},{"pmid":"37657916","id":"PMC_37657916","title":"TBX20 loss-of-function variants in families with left ventricular non-compaction cardiomyopathy.","date":"2024","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37657916","citation_count":4,"is_preprint":false},{"pmid":"39028008","id":"PMC_39028008","title":"Effect of Intramyocardial Administration of Baculovirus Encoding the Transcription Factor Tbx20 in Sheep With Experimental Acute Myocardial Infarction.","date":"2024","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/39028008","citation_count":3,"is_preprint":false},{"pmid":"23936153","id":"PMC_23936153","title":"Lack of genetic interaction between Tbx20 and Tbx3 in early mouse heart development.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23936153","citation_count":3,"is_preprint":false},{"pmid":"28525297","id":"PMC_28525297","title":"Association Analysis of Nonsyndromic Congenital Heart Disease and Tag Single Nucleotide Polymorphisms of TBX20 and Genes in the Ras-MAPK Pathway.","date":"2017","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/28525297","citation_count":3,"is_preprint":false},{"pmid":"37756602","id":"PMC_37756602","title":"The Tbx20-TLE interaction is essential for the maintenance of the second heart field.","date":"2023","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/37756602","citation_count":2,"is_preprint":false},{"pmid":"38479330","id":"PMC_38479330","title":"Generation of a TBX20 homozygous knockout stem cell line (WAe009-A-1E) by episomal vector-based CRISPR/Cas9 system.","date":"2024","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/38479330","citation_count":2,"is_preprint":false},{"pmid":"39777589","id":"PMC_39777589","title":"Exploring genetic mapping and co-expression patterns to illuminate significance of Tbx20 in cardiac biology.","date":"2025","source":"Transgenic research","url":"https://pubmed.ncbi.nlm.nih.gov/39777589","citation_count":2,"is_preprint":false},{"pmid":"40075846","id":"PMC_40075846","title":"Chromosomal Location and Identification of TBX20 as a New Gene Responsible for Familial Bicuspid Aortic Valve.","date":"2025","source":"Diagnostics (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/40075846","citation_count":2,"is_preprint":false},{"pmid":"35282022","id":"PMC_35282022","title":"A novel de novo TBX20 variant in a 6-year-old Chinese girl with left ventricular noncompaction: a case report.","date":"2022","source":"Translational pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/35282022","citation_count":2,"is_preprint":false},{"pmid":"41413924","id":"PMC_41413924","title":"MiR-101-3p Promotes Cardiac Senescence and Inflammation via Targeting Tbx20 and Bmp2 to Perturb Cardiac Homeostasis.","date":"2025","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/41413924","citation_count":1,"is_preprint":false},{"pmid":"39681102","id":"PMC_39681102","title":"The Role of TBX20 Gene Mutations in the Pathogenesis of Congenital Heart Disease: Functional Analysis and Genetic Association Study.","date":"2024","source":"Cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/39681102","citation_count":1,"is_preprint":false},{"pmid":"40889204","id":"PMC_40889204","title":"β-Sitosterol as an Anti-Tumour Active Component of Herba Sarcandrae Inhibits Colorectal Cancer Progression Through Up-Regulation of TBX20.","date":"2025","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40889204","citation_count":1,"is_preprint":false},{"pmid":"26675025","id":"PMC_26675025","title":"[Association between Tbx20 gene polymorphism and congenital atrial septal defects].","date":"2015","source":"Zhonghua nei ke za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/26675025","citation_count":1,"is_preprint":false},{"pmid":"30512176","id":"PMC_30512176","title":"[Role of Tbx20 gene in the development of cardiac valves].","date":"2018","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30512176","citation_count":0,"is_preprint":false},{"pmid":"40760458","id":"PMC_40760458","title":"Structural and functional assessment of TBX20 gene variants in pediatric ventricular septal defect.","date":"2025","source":"Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/40760458","citation_count":0,"is_preprint":false},{"pmid":"40273622","id":"PMC_40273622","title":"Enhanced BMP signaling in cranial neural crest cells induces aberrant chondrogenesis by upregulating Tbx20 expression during craniofacial development.","date":"2025","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/40273622","citation_count":0,"is_preprint":false},{"pmid":"36963213","id":"PMC_36963213","title":"Generation of a TBX20-knockout human embryonic stem line by CRISPR/Cas9 system.","date":"2023","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/36963213","citation_count":0,"is_preprint":false},{"pmid":"41993851","id":"PMC_41993851","title":"TBX20 regulates epithelial-mesenchymal transition, maintains tumor stemness and immune factor expression, and promotes immune escape in lung cancer.","date":"2026","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/41993851","citation_count":0,"is_preprint":false},{"pmid":"40719322","id":"PMC_40719322","title":"Variable Intrafamilial Cardiac Phenotype Segregating With a TBX20 Missense Variant in the Putative Transcriptional Activation Domain.","date":"2025","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/40719322","citation_count":0,"is_preprint":false},{"pmid":"42235376","id":"PMC_42235376","title":"Tbx20 and Sirt1 synergize to ameliorate cardiac aging through enhanced autophagy.","date":"2026","source":"Tissue & cell","url":"https://pubmed.ncbi.nlm.nih.gov/42235376","citation_count":0,"is_preprint":false},{"pmid":"31030447","id":"PMC_31030447","title":"[TBX20 - an important target gene for the prevention and treatment of cardiovascular diseases].","date":"2019","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31030447","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.29.651262","title":"Tbr2-Dependent Parallel Pathways Regulate the Development of Distinct ipRGC Subtypes","date":"2025-05-01","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.29.651262","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.11.20.25340640","title":"Integrative observational and genetic evidence from the UK Biobank supports carotid intima-media thickness as a window into cardiac remodeling","date":"2025-11-21","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.20.25340640","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50117,"output_tokens":8763,"usd":0.140898,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18597,"output_tokens":5354,"usd":0.113418,"stage2_stop_reason":"end_turn"},"total_usd":0.254316,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"TBX5 and TBX20 physically interact; interaction domains were mapped by pulldown assays in Xenopus, and the two proteins act synergistically during early heart development. Blocking either gene alone produces similar cardiac phenotypes, demonstrating non-redundant but cooperative roles.\",\n      \"method\": \"Co-immunoprecipitation / pulldown, morpholino knockdown, cardiac physiology analysis in Xenopus\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal physical interaction mapped with domain analysis, supported by in vivo genetic synergy in Xenopus and replicated context in multiple papers\",\n      \"pmids\": [\"15634698\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The C-terminal region of TBX20 functions as a transcriptional repressor, while the C-terminus of TBX5 is an activator. TBX20 represses the ANF promoter activity via TBE2, and also inhibits TBX5-mediated activation. BMP2, but not BMP2 for TBX5, induces TBX20 expression in cardiogenic explants.\",\n      \"method\": \"Luciferase reporter assays in cultured cells, promoter deletion analysis, recombinant BMP2 treatment of chick cardiogenic explants, real-time RT-PCR\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro transcriptional assays with deletion mutants identifying functional domains, combined with explant BMP2 induction experiment\",\n      \"pmids\": [\"14978031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Tbx20 loss-of-function in mice causes ectopic activation of Tbx2 across the entire heart myogenic field; Tbx20 is a transcriptional repressor that acts upstream of Tbx2 in the cardiac genetic hierarchy, placing Tbx20 upstream of Tbx2 in chamber vs. non-chamber myocardium lineage decisions.\",\n      \"method\": \"Gene targeting (knockout mouse), in situ hybridization, molecular marker analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout with defined molecular phenotype, replicated in multiple independent mouse knockout papers\",\n      \"pmids\": [\"15843414\", \"15901664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Complete Tbx20 knockdown in mouse embryos causes hypoplasia of the outflow tract and right ventricle with decreased expression of Nkx2-5 and Mef2c. Tbx20 synergizes with Isl1 and Gata4 to activate both the Mef2c AHF enhancer and the Nkx2-5 cardiac enhancer in cultured cells, providing a mechanism for gene activation in the anterior heart field.\",\n      \"method\": \"Transgenic RNA interference in ES cell-derived mouse embryos, luciferase reporter/enhancer assays, transgenic mouse enhancer analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — graded loss-of-function series combined with enhancer assays and in vivo transgenic validation; two independent papers confirm Tbx20 upstream of Nkx2-5/Mef2c\",\n      \"pmids\": [\"15843409\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Missense mutation I152M within the TBX20 T-box DNA-binding domain disrupts the structure and function of the TBX20 T-box as shown by biophysical characterization of purified recombinant wild-type and mutant proteins. TBX20 physically interacts with NKX2-5, GATA4, and TBX5.\",\n      \"method\": \"Biophysical characterization of recombinant proteins (circular dichroism, fluorescence), functional assays of mutant proteins\",\n      \"journal\": \"American Journal of Human Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biophysical characterization with wild-type vs. mutant protein comparison; previously known interaction partners confirmed\",\n      \"pmids\": [\"17668378\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Tbx20 suppresses Tbx2 expression in developing cardiac chambers not by direct transcriptional repression of the Tbx2 gene, but by binding Smad1 and Smad5 and sequestering them from Smad4, thereby attenuating BMP/Smad-dependent activation of Tbx2. This was demonstrated using transfection and co-localization studies with DNA-binding-deficient Tbx20 mutants.\",\n      \"method\": \"Tbx20/Tbx2 single and double knockout mouse embryos, transfection assays, co-immunoprecipitation of Tbx20 with Smad1/Smad5, localization studies, BMP/Smad enhancer analysis\",\n      \"journal\": \"Circulation Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — physical interaction (Tbx20-Smad1/5) confirmed by Co-IP, mechanism validated with DNA-binding mutant Tbx20, supported by double-KO genetic epistasis\",\n      \"pmids\": [\"19661464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The TBX20 T-box preferentially binds a T-half-site as optimal DNA recognition sequence, and distinct T-boxes show significant differences in binding affinity, kinetics, and conformational stability; the Tbx20 T-box exhibits molten globule character as shown using purified recombinant domains.\",\n      \"method\": \"In vitro DNA-binding assays with purified recombinant T-box domains, SELEX-type binding site determination, biophysical characterization (circular dichroism)\",\n      \"journal\": \"Journal of Molecular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted in vitro binding with purified domains, biophysical characterization, single study with multiple orthogonal methods\",\n      \"pmids\": [\"19414016\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"A gain-of-function mutation I121M in the TBX20 T-box domain alters tertiary hydrophobic interactions producing a more dynamic protein structure, leading to enhanced transcriptional activity and increased co-factor interactions with GATA4/5 and NKX2-5, as well as increased occupancy on target gene DNA.\",\n      \"method\": \"Surface plasmon resonance, CD spectropolarimetry, fluorescence spectrophotometry, luciferase assay, chromatin immunoprecipitation\",\n      \"journal\": \"Journal of Medical Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal biophysical and functional methods in single study characterizing gain-of-function mechanism\",\n      \"pmids\": [\"19762328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"BMP/SMAD1 signaling directly activates Tbx20 transcription through a conserved 334 bp cardiac regulatory element containing novel non-canonical SMAD-binding sites; phospho-SMAD1 directly binds this element in vivo. Blocking SMAD1 signaling specifically abolishes Tbx20 transcription in the developing heart.\",\n      \"method\": \"Transgenic reporter analysis in Xenopus and zebrafish and mouse; SMAD1 ChIP in vivo; SMAD1-binding site mutagenesis; morpholino knockdown of SMAD1 signaling\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct ChIP of phospho-SMAD1 on Tbx20 enhancer, mutagenesis of binding sites, and transgenic validation in three species\",\n      \"pmids\": [\"20460370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Tbx20 is a downstream transcriptional mediator of BMP10; BMP10 induces Tbx20 promoter activity through a conserved Smad binding site in the Tbx20 promoter proximal region. Tbx20 overexpression in myocardium phenocopies elevated BMP10 effects on ventricular wall development.\",\n      \"method\": \"Affymetrix exon arrays, quantitative RT-PCR, in situ hybridization, promoter luciferase assay with Smad binding site analysis, transgenic mouse overexpression\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — promoter Smad binding site identified and functionally validated, phenocopy in transgenic mice, multiple orthogonal methods\",\n      \"pmids\": [\"21890625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Myocardial Tbx20 is required for AVC constriction and endocardial EMT; Tbx20 maintains Bmp2 expression in AVC myocardium, and re-expression of Bmp2 substantially rescues the EMT defects caused by Tbx20 loss, establishing a Tbx20→Bmp2 pathway in AVC development.\",\n      \"method\": \"Conditional knockout mouse (AVC myocardium), in situ hybridization, rescue experiment with Bmp2 re-expression\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with specific cellular phenotype, genetic rescue with Bmp2 confirms epistatic relationship\",\n      \"pmids\": [\"21983003\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Adult cardiomyocyte-specific ablation of Tbx20 results in rapid onset of severe cardiomyopathy with arrhythmias and death within 1–2 weeks. Genome-wide ChIP analysis identified direct Tbx20 binding targets in adult heart including ion channel, cytoskeletal, and transcription factor genes; a novel DNA-binding site for Tbx20 was also identified.\",\n      \"method\": \"Conditional adult cardiomyocyte-specific Tbx20 knockout, genome-wide ChIP-seq, transcriptome analysis\",\n      \"journal\": \"Journal of Clinical Investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-seq combined with conditional KO and transcriptome analysis; replicated in subsequent paper (PMID 22328084)\",\n      \"pmids\": [\"22080862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Genome-wide ChIP coupled with RNA-seq in adult Tbx20 conditional KO hearts revealed TBX20 functions as both a transcriptional activator and repressor, each function regulating distinct gene programs. TBX20 binds targets in a context-dependent manner, using different cohorts of co-factors.\",\n      \"method\": \"Genome-wide ChIP-seq, RNA-seq, conditional adult cardiomyocyte KO\",\n      \"journal\": \"Human Molecular Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP + transcriptome in same KO model, two orthogonal methods in single lab building on PMID 22080862\",\n      \"pmids\": [\"22328084\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Tbx20 associates with a chromatin remodeling complex composed of TLE/Groucho corepressors, NuRD complex members, RUVBL1/RUVBL2, and T-box repressor Tbx18. The interaction with TLE corepressors is mediated via an EH1 (engrailed homology 1) motif in Tbx20; ablation of this motif disrupts the repression network and Tbx20 function in vivo.\",\n      \"method\": \"Immunoaffinity purification of tagged Tbx20 + GeLC-MS/MS proteomics, Co-IP validation in embryonic mouse heart, EH1 motif mutagenesis in vivo\",\n      \"journal\": \"Journal of Proteome Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — unbiased proteomics + reciprocal Co-IP in embryonic heart + in vivo mutagenesis of interaction motif; multiple orthogonal methods\",\n      \"pmids\": [\"24024827\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Tbx20 overexpression in postnatal and adult cardiomyocytes activates BMP2/pSmad1/5/8 and PI3K/AKT/GSK3β/β-catenin signaling pathways, promoting cardiomyocyte proliferation; inhibition of PI3K/AKT/GSK3β/β-catenin reduces but does not eliminate Tbx20-mediated proliferation, indicating parallel regulatory pathways downstream of BMP/Smad1/5/8.\",\n      \"method\": \"Cardiomyocyte-specific Tbx20 gain-of-function mouse, neonatal rat cardiomyocyte culture, PI3K inhibition, Western blot for pathway intermediates\",\n      \"journal\": \"Journal of Molecular and Cellular Cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo gain-of-function plus in vitro pathway inhibition, single lab, two orthogonal methods\",\n      \"pmids\": [\"23751911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Endocardial Tbx20 is required for valve endocardial cell proliferation and extracellular matrix development but not for initiation of EMT. Tbx20 ablation in endocardial cells causes aberrant Wnt/β-catenin signaling, and Tbx20 regulates Lef1, a key transcriptional mediator of Wnt/β-catenin signaling.\",\n      \"method\": \"Endocardial-specific conditional Tbx20 knockout, β-catenin immunostaining, qRT-PCR for Wnt target genes\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with defined molecular pathway, single lab\",\n      \"pmids\": [\"23824573\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Tbx20 overexpression in adult cardiomyocytes directly represses cell-cycle inhibitory genes p21, Meis1, and Btg2 as demonstrated by ChIP in neonatal cardiomyocytes. Tbx20 overexpression activates multiple pro-proliferation pathways including Akt, YAP, and BMP.\",\n      \"method\": \"Adult cardiomyocyte-specific Tbx20 overexpression in mice, ChIP assay for direct binding to p21/Meis1/Btg2 promoters, cardiac functional assessment after MI\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrates direct Tbx20 binding to target cell-cycle inhibitory genes, supported by in vivo gain-of-function with multiple functional readouts\",\n      \"pmids\": [\"26841808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TBX20 controls expression of the KCNH2 gene (encoding hERG channels) in human iPSC-derived cardiomyocytes; Tbx20 enhances KCNH2 gene expression and hERG currents, shortening action potential duration. A TBX20 p.R311C mutation specifically disables TBX20's pro-transcriptional activity over KCNH2 without affecting nuclear distribution.\",\n      \"method\": \"hiPSC-derived cardiomyocytes, electrophysiology (patch clamp), RT-qPCR, gene expression analysis of other channels\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional electrophysiology in human iPSC-CMs combined with mutant analysis, direct measurement of KCNH2/hERG current\",\n      \"pmids\": [\"28049825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TBX20 physically and genetically interacts with transcription factor CASZ1; this interaction is required for survival since double heterozygous Tbx20/Casz1 mice die postnatally of dilated cardiomyopathy. A DCM-associated TBX20 mutation sterically disrupts the TBX20-CASZ1 interaction. Quantitative proteomics defined molecular pathways mis-regulated upon disruption of this complex.\",\n      \"method\": \"Unbiased proteomic screen (immunoaffinity purification + MS), Co-IP, structural studies, Tbx20+Casz1 double heterozygous mouse genetic model, quantitative proteomics\",\n      \"journal\": \"PLoS Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, structural basis of interaction, genetic epistasis in double-het mice, quantitative proteomics; multiple orthogonal methods\",\n      \"pmids\": [\"28945738\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TBX20 regulates angiogenesis through transcriptional activation of PROK2 (prokineticin 2); TBX20 knockdown reduces PROK2 expression and impairs endothelial cell migration and angiogenesis. Overexpression of prok2 or prokr1a rescues impaired angiogenesis in tbx20-deficient zebrafish, placing TBX20 upstream of the PROK2-PROKR1 pathway.\",\n      \"method\": \"TBX20 siRNA knockdown, Matrigel plug angiogenesis assay, zebrafish tbx20 morpholino and CRISPR/Cas9 knockout, prok2/prokr1a overexpression rescue, angiogenesis gene array\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function in multiple systems (cell culture, mouse, zebrafish), genetic rescue experiments establishing epistasis, gene array identification of downstream target\",\n      \"pmids\": [\"29545372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Mid-gestation cardiomyocyte-specific Tbx20 ablation reduces cardiomyocyte proliferation and arrests cells at G1-S phase transition. TBX20 ChIP-seq from embryonic heart identified direct targets including key cell cycle genes and atrial/ventricular specific genes. TBX20 binds a conserved enhancer for COUP-TFII/Nr2f2 and directly activates genes required for atrial identity.\",\n      \"method\": \"Inducible cardiomyocyte-specific Tbx20 KO, cell cycle analysis, genome-wide transcriptome, TBX20 ChIP-seq from embryonic heart, transgenic enhancer assay\",\n      \"journal\": \"Circulation Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq plus conditional KO plus transgenic enhancer validation; multiple orthogonal methods in one study\",\n      \"pmids\": [\"29903739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Endocardial TBX20 directly regulates versican (Vcan) expression through binding to a conserved long-range enhancer identified by ATAC-seq and ChIP-seq intersection with chromatin loop maps. The Vcan enhancer drives reporter expression in endocardial lineages in a TBX20-binding site-dependent manner.\",\n      \"method\": \"Endocardial Tbx20 conditional KO, ATAC-seq, TBX20 ChIP-seq, Hi-C chromatin loop maps, transgenic reporter assay with TBX20 binding site mutation\",\n      \"journal\": \"Journal of Clinical Investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ATAC-seq + ChIP-seq + Hi-C + transgenic reporter with binding site mutagenesis; multiple orthogonal methods identifying direct regulatory mechanism\",\n      \"pmids\": [\"27348591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Tbx20 is required for tangential migration of facial motor neurons, lateral migration of trigeminal cells, and trans-median movement of vestibuloacoustic neurons. Facial cell migration defects were associated with coordinate downregulation of multiple planar cell polarity pathway components (Fzd7, Wnt11, Prickle1, Vang1, Vang2), identifying Tbx20 as a positive regulator of non-canonical Wnt signaling in these neurons.\",\n      \"method\": \"Conditional Tbx20-null mice (neuron-specific deletion), in situ hybridization, immunohistochemistry for PCP pathway components\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with specific migration phenotype and molecular pathway correlation; single lab\",\n      \"pmids\": [\"17119020\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Tbx20 directly regulates Esrra (estrogen-related receptor alpha) expression as determined by ChIP analysis; Tbx20 overexpression reduces H2O2-induced cardiomyocyte apoptosis via inhibition of p38MAPK, Bax, and caspase3 and activation of Bcl-2. Estrogen upregulates Tbx20 expression to mediate cardioprotection.\",\n      \"method\": \"ChIP assay for Tbx20 binding to Esrra locus, Tbx20 overexpression/knockdown in neonatal rat cardiomyocytes and H9c2 cells, Western blot for apoptotic markers\",\n      \"journal\": \"International Journal of Cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP shows direct Tbx20-Esrra interaction, combined with functional apoptosis assays; single lab\",\n      \"pmids\": [\"23871353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MKLN1 (muskelin) directly binds the T-box DNA-binding domain of TBX20b isoform (but not other TBX20 isoforms) via its kelch repeats domain; the two proteins co-localize primarily in the cytoplasm when co-transfected. The interaction was identified by yeast two-hybrid screening of embryonic mouse heart cDNA library.\",\n      \"method\": \"Yeast two-hybrid screen, domain-mapping in mammalian cells, immunofluorescence colocalization, immunohistochemistry in embryonic mouse hearts\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — yeast two-hybrid plus cellular colocalization; isoform specificity characterized but functional consequence not fully established\",\n      \"pmids\": [\"21586270\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TBX20 colocalizes with MEF2C, GATA4, and TBX5 (MGT) at cardiac gene enhancers associated with heart contraction in human iPSC-derived cardiomyocytes, promotes chromatin binding and co-occupancy of MGT factors at these loci, and synergizes for more robust activation of target gene transcription. Mechanistically shown by ChIP-seq and ATAC-seq.\",\n      \"method\": \"Transcriptomic comparison, ChIP-seq, ATAC-seq, human direct cardiac reprogramming, functional assays (contractility, calcium oscillation, mitochondrial respiration)\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq + ATAC-seq + epigenomic approaches in human reprogramming system with functional validation; multiple orthogonal methods\",\n      \"pmids\": [\"36102189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Tbx20 induction in adult zebrafish myocardium promotes cardiomyocyte dedifferentiation (loss of cellular contacts, re-expression of fetal gene programs) and non-cell-autonomously induces endocardial Bmp6 signaling. Pharmacological inhibition of endocardial Bmp6 attenuates endocardial regeneration in tbx20-overexpressing hearts.\",\n      \"method\": \"Adult zebrafish cardiac injury models, cardiomyocyte-specific Tbx20 overexpression, pharmacological Bmp6 inhibition, Id1/Id2b expression analysis\",\n      \"journal\": \"Frontiers in Cell and Developmental Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo gain-of-function with pharmacological pathway inhibition; single lab in zebrafish\",\n      \"pmids\": [\"32850848\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TFAP2 transcription factors function as repressors of the TBX20 gene in vitro and in vivo through functional binding sites within a 100 bp core promoter region of human TBX20; decreased TFAP2C levels were found in cardiac biopsies of TOF patients.\",\n      \"method\": \"TBX20 promoter luciferase reporter assay, identification of TFAP2 binding sites, in vivo validation in cardiac biopsies\",\n      \"journal\": \"Journal of Cellular Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional promoter analysis with binding site identification plus in vivo biological context; single lab\",\n      \"pmids\": [\"18275040\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TBX20 suppresses colorectal cancer cell proliferation by impairing non-homologous end joining (NHEJ)-mediated DNA double-strand break repair via direct binding to the middle domains of both Ku70 and Ku80, inhibiting their recruitment to chromatin. PDZRN3 was identified as the E3 ubiquitin ligase mediating TBX20 ubiquitination and degradation.\",\n      \"method\": \"Co-immunoprecipitation with Ku70/Ku80 domain mapping, chromatin fractionation, NHEJ repair assay, ubiquitination assay identifying PDZRN3 as E3 ligase\",\n      \"journal\": \"Cancer Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with domain mapping, chromatin recruitment assay, and ubiquitination assay; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"35348274\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ER stress upregulates Tbx20 via the ATF6 arm of the unfolded protein response; Tbx20 in turn activates downstream BMP2-pSmad1/5/8 signaling to induce cardiomyocyte proliferation and limit apoptosis. Administration of recombinant Bmp2 further upregulates Tbx20, establishing a feed-forward loop.\",\n      \"method\": \"ER stress induction in neonatal rat cardiomyocytes and in vivo, ATF6 pathway inhibition, Tbx20 cardiomyocyte-specific conditional KO, recombinant Bmp2 rescue experiment, Western blot for pSmad1/5/8\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO + pharmacological pathway dissection + genetic rescue; single lab\",\n      \"pmids\": [\"36805334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TBX20 mutations p.His232Arg and p.Asp288His reduce transactivation of the KCNH2 target gene and impair binding to the KCNH2 promoter without affecting nuclear distribution of TBX20; these mutations co-segregate with atrial fibrillation and map to a new AF locus at chromosome 7p14.2-p14.3.\",\n      \"method\": \"Linkage analysis, exome sequencing, Sanger sequencing, dual-luciferase reporter assay, promoter-binding assay\",\n      \"journal\": \"Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — reporter assay and DNA binding assay with mutant proteins; functional demonstration of mechanism but no ChIP or in vivo validation\",\n      \"pmids\": [\"37759586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Disruption of the Tbx20-TLE interaction (via EH1 domain two-amino-acid substitution knock-in mouse) impairs cardiac looping and chamber formation, with transcriptional profiling revealing misexpression of the retinoic acid pathway and cardiac progenitor genes in the second heart field.\",\n      \"method\": \"EH1 domain knock-in mouse model (two amino acid substitution disrupting TLE interaction), RNA-seq transcriptional profiling, cardiac morphology analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — targeted in vivo mutagenesis of specific interaction domain with defined morphogenetic and transcriptional phenotype; validates earlier proteomic discovery (PMID 24024827)\",\n      \"pmids\": [\"37756602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Tbx20 directly activates Hey2 expression in embryonic mouse ventricles through a distal enhancer; mutation/deletion of conserved T-box binding sites in the enhancer abolishes activity, and Tbx20 null mice completely lose the enhancer activity. Luciferase assays show Tbx20 controls enhancer activity through DNA binding and cooperative function with cardiac Gata proteins.\",\n      \"method\": \"Enhancer deletion mouse model, Tbx20 null mouse enhancer analysis, luciferase reporter assays with T-box and Gata binding site mutations\",\n      \"journal\": \"Developmental Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo enhancer deletion + Tbx20 null validation + luciferase with site mutagenesis; multiple orthogonal methods\",\n      \"pmids\": [\"32035085\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In retinal ganglion cells, Tbx20 is expressed predominantly in M1, M2, M6 ipRGC subtypes and is required for their development; conditional deletion of Tbx20 causes failure of Tbx20-expressing cells to develop and downregulates Opn4 expression, establishing Tbx20 as a key downstream factor of Tbr2 in ipRGC subtype specification.\",\n      \"method\": \"Conditional Tbx20 deletion in retinal neurons (Tbr2-Cre), single-cell RNA-seq subtype profiling, Opn4 expression analysis\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — conditional KO with defined cellular phenotype in retina; preprint, not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.04.29.651262\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"TBX20 is a T-box transcription factor that functions as both a transcriptional activator and repressor in the heart by binding T-half-site DNA sequences and assembling context-dependent complexes: it interacts with cardiac co-factors NKX2-5, GATA4, TBX5, ISL1, and CASZ1 to activate chamber-specific gene programs (including KCNH2/hERG, Hey2, COUP-TFII enhancers, and cell-cycle genes), while recruiting a TLE/Groucho-NuRD corepressor complex via its EH1 motif to repress Tbx2 and other non-chamber genes, with BMP/SMAD1 signaling acting directly upstream to drive Tbx20 transcription, and Tbx20 itself attenuating BMP/Smad signaling by sequestering Smad1/5 from Smad4 to restrict Tbx2 to the AVC; in adult cardiomyocytes, Tbx20 maintains ion channel and cytoskeletal gene expression, directly represses cell-cycle inhibitors p21/Meis1/Btg2 to promote proliferation, and regulates angiogenesis via the PROK2-PROKR1 pathway.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TBX20 is a cardiac T-box transcription factor that binds T-half-site DNA and acts as both an activator and a repressor to assemble context-dependent regulatory complexes governing chamber specification, cardiomyocyte proliferation, and adult heart homeostasis [#6, #12]. As an activator, TBX20 synergizes with the core cardiac cofactors NKX2-5, GATA4, TBX5, ISL1, MEF2C and CASZ1 to drive enhancers for anterior-heart-field genes (Mef2c, Nkx2-5), chamber-identity genes (Hey2, COUP-TFII/Nr2f2), and the hERG channel gene KCNH2, and to direct atrial/ventricular gene programs [#3, #4, #18, #20, #25, #32, #17]. As a repressor, TBX20 recruits a TLE/Groucho-NuRD corepressor complex (with RUVBL1/2 and TBX18) through an EH1 motif, an interaction required for cardiac looping and chamber formation [#13, #31]. TBX20 restricts the non-chamber gene Tbx2 to the AVC not by direct repression but by binding SMAD1/SMAD5 and sequestering them from SMAD4, thereby attenuating BMP/Smad signaling [#5, #2]. BMP/SMAD1 signaling, in turn, acts directly upstream to activate Tbx20 transcription, creating a regulatory circuit [#8, #9]. In adult and postnatal cardiomyocytes TBX20 maintains ion-channel and cytoskeletal gene expression, and promotes proliferation by directly repressing the cell-cycle inhibitors p21, Meis1 and Btg2 and by engaging BMP/Smad and PI3K/AKT pathways [#11, #16, #14, #20]. TBX20 also regulates endocardial valve development through versican and Wnt/Lef1 [#21, #15] and controls angiogenesis via the PROK2-PROKR1 pathway [#19]. Disease-associated T-box mutations alter protein structure, cofactor binding, and target activation: structural T-box mutations cause congenital heart defects [#4, #7], a CASZ1-disrupting mutation underlies dilated cardiomyopathy [#18], and KCNH2-promoter-binding mutations co-segregate with atrial fibrillation [#30, #17]. Beyond the heart, TBX20 functions in facial/vestibuloacoustic neuron migration via planar cell polarity components [#22] and in retinal ganglion cell subtype specification [#33].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Established that TBX20 carries an intrinsic transcriptional repressor function distinct from the activator TBX5 and that BMP2 induces its expression, framing TBX20 as a BMP-responsive repressive arm of cardiac gene control.\",\n      \"evidence\": \"Luciferase reporter/promoter deletion assays and BMP2 treatment of chick cardiogenic explants\",\n      \"pmids\": [\"14978031\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vitro reporter context only\", \"Endogenous repression targets not yet defined\", \"BMP-to-Tbx20 enhancer not yet mapped\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined TBX20's place in the cardiac genetic hierarchy: it physically partners with TBX5 and acts upstream of Tbx2 to enforce chamber versus non-chamber myocardium identity, and synergizes with Isl1/Gata4 to activate Nkx2-5 and Mef2c in the anterior heart field.\",\n      \"evidence\": \"Co-IP and morpholino knockdown in Xenopus, knockout mice with marker analysis, enhancer/luciferase and transgenic assays\",\n      \"pmids\": [\"15634698\", \"15843414\", \"15901664\", \"15843409\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of Tbx2 repression unresolved at this stage\", \"Direct vs indirect activation of Nkx2-5/Mef2c not separated\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Resolved how TBX20 represses Tbx2 — not by direct DNA binding but by sequestering SMAD1/5 from SMAD4 — and defined its preferred T-half-site recognition sequence with molten-globule biophysics of the T-box.\",\n      \"evidence\": \"Single/double knockout mice, Co-IP of Tbx20 with Smad1/5, DNA-binding-deficient mutants, SELEX-type binding and CD on purified domains\",\n      \"pmids\": [\"19661464\", \"19414016\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of Smad sequestration not quantified\", \"Genome-wide direct binding map still absent\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Closed the regulatory loop upstream of TBX20 by showing phospho-SMAD1 directly binds a conserved cardiac enhancer to activate Tbx20 transcription, and that BMP10 feeds the same Smad-dependent promoter element.\",\n      \"evidence\": \"In vivo SMAD1 ChIP, binding-site mutagenesis, transgenic reporters across three species, BMP10 promoter assays and overexpression mice\",\n      \"pmids\": [\"20460370\", \"21890625\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific cofactors at the SMAD enhancer not defined\", \"Feedback timing relative to Tbx20-Smad sequestration not modeled\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrated TBX20 is continuously required in the adult heart for survival and identified its genome-wide direct targets, establishing a maintenance role over ion-channel, cytoskeletal, and transcription-factor genes; also placed Tbx20 upstream of Bmp2 in AVC EMT.\",\n      \"evidence\": \"Conditional adult cardiomyocyte KO with genome-wide ChIP-seq and transcriptomics; conditional AVC KO with Bmp2 rescue\",\n      \"pmids\": [\"22080862\", \"21983003\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Activator vs repressor target partition not yet separated\", \"Cofactor identity at adult binding sites unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Resolved that TBX20 operates as both activator and repressor over distinct gene cohorts in a context-dependent, cofactor-dependent manner.\",\n      \"evidence\": \"Genome-wide ChIP-seq plus RNA-seq in adult conditional KO hearts\",\n      \"pmids\": [\"22328084\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific cofactors that switch activator/repressor mode not all identified\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined the molecular machinery of TBX20-mediated repression — an EH1-tethered TLE/Groucho-NuRD-RUVBL1/2-TBX18 complex — and linked TBX20 gain-of-function to proliferative BMP/Smad and PI3K/AKT signaling and to endocardial Wnt/Lef1 control.\",\n      \"evidence\": \"Tagged-Tbx20 immunoaffinity proteomics with Co-IP and EH1 mutagenesis; gain-of-function mice with pathway inhibition; endocardial conditional KO with Wnt target analysis\",\n      \"pmids\": [\"24024827\", \"23751911\", \"23824573\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect contribution of each corepressor subunit unresolved\", \"Proliferation pathway findings from a single lab\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established the direct mechanism by which TBX20 drives cardiomyocyte proliferation — repression of the cell-cycle inhibitors p21, Meis1, and Btg2 — and mapped a direct endocardial enhancer for versican.\",\n      \"evidence\": \"ChIP for direct promoter binding plus in vivo gain-of-function after MI; ATAC-seq/ChIP-seq/Hi-C with binding-site-mutant reporter for Vcan\",\n      \"pmids\": [\"26841808\", \"27348591\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Durability of induced proliferation not established\", \"Endocardial vs myocardial target overlap not compared\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Connected TBX20 to specific channelopathy and cardiomyopathy mechanisms: it activates KCNH2/hERG to shape action potential duration, and a CASZ1-binding interaction is required to prevent dilated cardiomyopathy.\",\n      \"evidence\": \"hiPSC-CM electrophysiology with mutant analysis; proteomics, Co-IP, structural studies and Tbx20/Casz1 double-het mice\",\n      \"pmids\": [\"28049825\", \"28945738\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full set of TBX20-CASZ1 co-regulated targets not enumerated\", \"hERG regulation mechanism (direct vs cofactor-dependent) at promoter level partly open\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extended TBX20 function beyond the cardiomyocyte: it activates PROK2 to drive angiogenesis, and embryonic ChIP-seq defined its direct atrial-identity targets (COUP-TFII/Nr2f2) and cell-cycle program controlling G1-S progression.\",\n      \"evidence\": \"siRNA/zebrafish loss-of-function with prok2/prokr1a rescue and gene arrays; inducible cardiomyocyte KO with ChIP-seq and transgenic enhancer assay\",\n      \"pmids\": [\"29545372\", \"29903739\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endothelial vs cardiac TBX20 cofactors not compared\", \"PROK2 regulatory element not finely mapped\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed that TBX20 acts within the MEF2C/GATA4/TBX5 reprogramming cohort to promote chromatin co-occupancy and synergistic activation of contraction-gene enhancers, and that it directly activates Hey2 through a Gata-cooperative ventricular enhancer; in adult zebrafish it drives dedifferentiation and endocardial Bmp6 signaling.\",\n      \"evidence\": \"ChIP-seq/ATAC-seq in human reprogramming with functional assays; Hey2 enhancer deletion/null mouse with luciferase site mutagenesis; zebrafish overexpression with Bmp6 inhibition\",\n      \"pmids\": [\"36102189\", \"32035085\", \"32850848\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Order of MGT factor recruitment vs TBX20 binding not fully resolved\", \"Zebrafish dedifferentiation findings from single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Validated the EH1-TLE repression circuit in vivo and elaborated stress-responsive and arrhythmia mechanisms: ER stress drives Tbx20 via ATF6 into a BMP2 feed-forward proliferative loop, and KCNH2-promoter-binding mutations co-segregate with atrial fibrillation.\",\n      \"evidence\": \"EH1 knock-in mouse with RNA-seq; ER-stress models with ATF6 inhibition, conditional KO and Bmp2 rescue; linkage/exome and reporter/binding assays for AF mutations\",\n      \"pmids\": [\"37756602\", \"36805334\", \"37759586\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stress-loop and AF mechanisms each from single studies\", \"AF mutations lack ChIP/in vivo validation\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified a non-cardiac tumor-suppressive role: TBX20 binds Ku70/Ku80 to inhibit their chromatin recruitment and NHEJ repair, with PDZRN3 controlling TBX20 turnover.\",\n      \"evidence\": \"Co-IP with domain mapping, chromatin fractionation, NHEJ repair and ubiquitination assays in colorectal cancer cells\",\n      \"pmids\": [\"35348274\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"In vivo relevance to tumor suppression not established\", \"Relationship to transcriptional function unclear\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended the developmental remit of TBX20 to retinal ganglion cell subtype specification downstream of Tbr2.\",\n      \"evidence\": \"Conditional Tbx20 deletion with single-cell RNA-seq and Opn4 analysis (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.04.29.651262\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, not peer-reviewed\", \"Direct vs indirect Opn4 regulation unknown\", \"Cofactors in RGCs undefined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How TBX20 selects between its activator and repressor cofactor cohorts at individual loci — the molecular switch governing context-dependent complex assembly — remains undefined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model of the full TBX20 holo-complexes\", \"Determinants of activator-vs-repressor mode selection unresolved\", \"Post-translational regulation of TBX20 beyond PDZRN3 ubiquitination not characterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [4, 12, 16, 20]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [6, 11, 32]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [28]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [17, 30]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [11, 13, 21]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [4, 12, 20]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 3, 32]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5, 8, 14]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [16, 20]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [28]}\n    ],\n    \"complexes\": [\n      \"TLE/Groucho-NuRD corepressor complex\",\n      \"MEF2C/GATA4/TBX5 (MGT) reprogramming complex\"\n    ],\n    \"partners\": [\n      \"TBX5\",\n      \"NKX2-5\",\n      \"GATA4\",\n      \"SMAD1\",\n      \"CASZ1\",\n      \"TLE\",\n      \"TBX18\",\n      \"MKLN1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":9,"faith_total":9,"faith_pct":100.0}}